Jiangsu Hengrui Medicine

Fast moving Chinese regulators wave third homegrown PD-1 to market
Endpoints
Fri, 05/31/19 - 11:51 pm
China
Jiangsu Hengrui Medicine
PD-1 inhibitors
China Biotech In Review: Sanofi In The Hunt For China M&A
Seeking Alpha
Sun, 04/7/13 - 11:00 am
Jiangsu Hengrui Medicine
Sanofi
Hangzhou Nurotron Biotechnology